1. 11β-HSD1 Inhibitors for the Treatment of Type 2 Diabetes and Cardiovascular Disease

   • Anna Anderson
   • Brian R. Walker

   Leading Article 29 August 2013 Pages: 1385 - 1393

2. The Optimal Management of Follicular Lymphoma: An Evolving Field

   • Chaitra Ujjani
   • Bruce D. Cheson

   Therapy in Practice 25 July 2013 Pages: 1395 - 1403

   

3. Non-dopaminergic Treatments for Motor Control in Parkinson’s Disease

   • Susan H. Fox

   Review Article 06 August 2013 Pages: 1405 - 1415

4. Rationale for and Review of Neoadjuvant Therapy Prior to Radical Prostatectomy for Patients with High-Risk Prostate Cancer

   • Rana R. McKay
   • Toni K. Choueiri
   • Mary-Ellen Taplin

   Review Article 13 August 2013 Pages: 1417 - 1430

   

5. HIV-Associated Lipodystrophy: Impact of Antiretroviral Therapy

   • Giovanni Guaraldi
   • Chiara Stentarelli
   • Antonella Santoro

   Review Article 04 September 2013 Pages: 1431 - 1450

6. Eplerenone: A Review of Its Use in Patients with Chronic Systolic Heart Failure and Mild Symptoms

   • Sohita Dhillon

   Adis Drug Evaluation 24 July 2013 Pages: 1451 - 1462

7. Natalizumab: A Review of Its Use in the Management of Relapsing-Remitting Multiple Sclerosis

   • Paul L. McCormack

   Adis Drug Evaluation 03 August 2013 Pages: 1463 - 1481

8. Sumatriptan Iontophoretic Transdermal System: A Review of Its Use in Patients with Acute Migraine

   • Karly P. Garnock-Jones

   Adis Drug Evaluation 03 August 2013 Pages: 1483 - 1490

   

9. Pertuzumab: A Review of Its Use for First-Line Combination Treatment of HER2-Positive Metastatic Breast Cancer

   • Paul L. McCormack

   Adis Drug Evaluation 28 August 2013 Pages: 1491 - 1502

   

10. Afatinib: First Global Approval

    • Rosselle T. Dungo
    • Gillian M. Keating

    R&D Insight Report 28 August 2013 Pages: 1503 - 1515